ImmuCell Corp (NASDAQ:ICCC)
| 5.24 Delayed Data As of 3:43pm ET |  +0.07 / +1.35%Today’s Change | 4.26 Today|||52-Week Range 9.61 | -14.10% Year-to-Date |
Latest ICCC News | Press Releases
No recent news for ImmuCell Corp.
Today’s Trading
| Previous close | 5.17 |
| Today’s open | 5.29 |
| Day’s range | 5.23 - 5.76 |
| Volume | 791 |
| Average volume (3 months) | 8,286 |
| Market cap | $39.3M |
Data as of 3:43pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -3,026.21% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -3.51% |
| P/E ratio | NM |
| Price/Sales | 2.54 |
| Price/Book | 1.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYBXSynlogic Inc | +0.01 | +2.14% |
| NCNANuCana PLC | 0.00 | 0.00% |
| ---- | ||
| MDNAMedicenna Therapeuti... | -0.03 | -4.97% |
Data as of 3:58pm ET, 06/09/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $18.6M |
| Annual profit (last year) | -$2.5M |
| Net profit margin | -13.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Portland, Maine |
Forecasts
